Shikonin/Galunisertib Dual-Drug Core–Shell Coaxial Gel/PCL Nanofibrous Membrane for Radiation-Induced Skin Injury
To develop an acetylshikonin/galunisertib dual-drug core–shell Gel/PCL nanofibrous membrane for radiation-induced skin injury.
Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine